Sheets Smith Investment Management »

Halozyme Therapeutics shares owned by Sheets Smith Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Sheets Smith Investment Management from 13F filings

Historical chart of Sheets Smith Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Sheets Smith Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Sheets Smith Investment Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $587k 12k 49.38
2022-06-30 $510k 12k 42.27
2020-12-31 $498k 12k 42.67